Region:Middle East
Author(s):Rebecca
Product Code:KRAD2785
Pages:82
Published On:November 2025
By Type:The market is segmented into various types of angina pectoris, including Stable Angina, Unstable Angina, Variant (Prinzmetal) Angina, Microvascular Angina, and Others. Among these, Stable Angina is the most prevalent type, primarily due to its association with chronic coronary artery disease. Patients often seek medical attention for stable angina, leading to a higher demand for treatment options. Unstable Angina is also significant, as it represents a medical emergency requiring immediate intervention. The increasing awareness of heart health and the need for effective management strategies contribute to the growth of these segments .
By Treatment Method:The treatment methods for angina pectoris include Medications, Surgical Procedures, Lifestyle Modifications, Cardiac Rehabilitation Programs, and Others. Medications, particularly nitrates and beta-blockers, dominate the market due to their effectiveness in managing symptoms and improving patient quality of life. Surgical procedures like Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) are also critical, especially for patients with severe conditions. The growing emphasis on lifestyle changes, digital health monitoring, and structured rehabilitation programs further supports the market's expansion .
The Oman Angina Pectoris Market is characterized by a dynamic mix of regional and international players. Leading participants such as Oman Medical Supplies & Services Co. LLC, Muscat Pharmacy & Stores LLC, Al Nahda Medical Company LLC, Gulf Pharmaceutical Industries (Julphar), Aster DM Healthcare, Al Hayat Pharmaceuticals, National Life & General Insurance Company SAOG, Al Jazeera Pharmaceutical Industries LLC, Dhofar Pharmaceutical Industries LLC, Oman Medical Specialty Board, Muscat Private Hospital, Sultan Qaboos University Hospital, The Royal Hospital (Oman), Al Noor Hospital (Oman), Oman International Hospital contribute to innovation, geographic expansion, and service delivery in this space.
The future of the angina pectoris market in Oman appears promising, driven by ongoing advancements in healthcare technology and increased public awareness. The integration of telemedicine is expected to enhance patient access to specialists, particularly in remote areas. Furthermore, the government's commitment to expanding healthcare infrastructure will likely facilitate better treatment options. As the population ages and the prevalence of cardiovascular diseases rises, the demand for innovative therapies and preventive measures will continue to grow, shaping the market landscape.
| Segment | Sub-Segments |
|---|---|
| By Type | Stable Angina Unstable Angina Variant (Prinzmetal) Angina Microvascular Angina Others |
| By Treatment Method | Medications Nitrates Beta Blockers Calcium Channel Blockers Antiplatelet Agents Statins Surgical Procedures Percutaneous Coronary Intervention (PCI) Coronary Artery Bypass Grafting (CABG) Lifestyle Modifications Cardiac Rehabilitation Programs Others |
| By Age Group | 30 Years 45 Years 60 Years Years and Above Others |
| By Gender | Male Female Others |
| By Severity | Mild Moderate Severe Others |
| By Geographic Distribution | Muscat Dhofar Al Batinah Al Dakhiliyah Others |
| By Healthcare Provider Type | Hospitals Specialized Cardiac Centers Clinics Home Healthcare Telehealth Services Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Cardiology Clinics | 100 | Cardiologists, Nurse Practitioners |
| Patient Support Groups | 80 | Angina Patients, Caregivers |
| Healthcare Administrators | 50 | Hospital Managers, Policy Makers |
| Pharmaceutical Representatives | 60 | Sales Managers, Medical Science Liaisons |
| Health Insurance Providers | 40 | Underwriters, Claims Adjusters |
The Oman Angina Pectoris Market is valued at approximately USD 15 million, reflecting a five-year historical analysis. This growth is attributed to the rising prevalence of cardiovascular diseases and advancements in medical technology.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
